We are live on ! Find out more
CA

Cliff Asness AQR Capital Management

AUM $287B
1-Year Est. Return 42.33%
 

Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.

This Fund
S&P 500
This Quarter Est. Return
+1%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$65.2B
AUM Growth
+$6.51B
Cap. Flow
+$6.71B
Cap. Flow %
10.29%
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$213M
2
CI icon
Cigna
CI
+$207M
3
CMCSA icon
Comcast
CMCSA
+$164M
4
ZM icon
Zoom
ZM
+$155M
5
JNJ icon
Johnson & Johnson
JNJ
+$139M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$237M
2
TSM icon
TSMC
TSM
+$214M
3
NVDA icon
NVIDIA
NVDA
+$138M
4
ADBE icon
Adobe
ADBE
+$133M
5
PHM icon
Pultegroup
PHM
+$124M

Sector Composition

Rank Sector Weight
1 Technology 24.59%
2 Financials 13.87%
3 Industrials 12.52%
4 Consumer Discretionary 12.44%
5 Healthcare 12.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACI icon
1676
Albertsons Companies
ACI
$6.1B
$1.2M ﹤0.01%
60,655
+933
+2% +$19.1K
DBI icon
1677
Designer Brands
DBI
$286M
$1.19M ﹤0.01%
174,576
-146,621
-46% -$1.3M
AVA icon
1678
Avista
AVA
$3.18B
$1.19M ﹤0.01%
34,376
+9,552
+38% +$341K
HWKN icon
1679
Hawkins
HWKN
$2.45B
$1.19M ﹤0.01%
13,027
+311
+2% +$25.5K
KYNB
1680
Kyntra Bio
KYNB
$32.3M
$1.18M ﹤0.01%
52,835
+30,784
+140% +$951K
PACK icon
1681
Ranpak Holdings
PACK
$436M
$1.18M ﹤0.01%
+183,227
New +$1.24M
FELE icon
1682
Franklin Electric
FELE
$4.51B
$1.17M ﹤0.01%
12,194
+2,302
+23% +$229K
ICHR icon
1683
Ichor Holdings
ICHR
$2.13B
$1.17M ﹤0.01%
+30,252
New +$1.15M
CHH icon
1684
Choice Hotels
CHH
$4.95B
$1.17M ﹤0.01%
9,851
-81,213
-89% -$9.58M
TAK icon
1685
Takeda Pharmaceutical
TAK
$58.4B
$1.16M ﹤0.01%
90,013
+54,539
+154% +$722K
AUPH icon
1686
Aurinia Pharmaceuticals
AUPH
$2.22B
$1.15M ﹤0.01%
+202,241
New +$1.07M
PKST
1687
DELISTED
Peakstone Realty Trust
PKST
$1.15M ﹤0.01%
108,887
+55,071
+102% +$724K
BGFV
1688
DELISTED
Big 5 Sporting Goods
BGFV
$1.15M ﹤0.01%
389,442
+4,821
+1% +$15.9K
DBND icon
1689
DoubleLine Opportunistic Bond ETF
DBND
$768M
$1.15M ﹤0.01%
25,359
+6,460
+34% +$292K
STBA icon
1690
S&T Bancorp
STBA
$1.76B
$1.14M ﹤0.01%
34,280
+9,384
+38% +$293K
DG icon
1691
Dollar General
DG
$27.1B
$1.14M ﹤0.01%
8,697
-16,171
-65% -$2.26M
WPC icon
1692
W.P. Carey
WPC
$16.4B
$1.13M ﹤0.01%
20,683
-3,444
-14% -$194K
VONG icon
1693
Vanguard Russell 1000 Growth ETF
VONG
$44.8B
$1.13M ﹤0.01%
+12,025
New +$1.06M
ESGV icon
1694
Vanguard ESG US Stock ETF
ESGV
$13.5B
$1.13M ﹤0.01%
11,664
DFSD
1695
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.23B
$1.13M ﹤0.01%
+23,964
New +$1.12M
CATY icon
1696
Cathay General Bancorp
CATY
$4.13B
$1.12M ﹤0.01%
29,804
+8,429
+39% +$306K
CRC icon
1697
California Resources
CRC
$4.62B
$1.12M ﹤0.01%
21,032
+11,205
+114% +$572K
ANIP icon
1698
ANI Pharmaceuticals
ANIP
$1.71B
$1.12M ﹤0.01%
17,527
+5,419
+45% +$352K
GNE icon
1699
Genie Energy
GNE
$402M
$1.12M ﹤0.01%
76,309
+38,632
+103% +$588K
DFUS
1700
Dimensional US Equity ETF
DFUS
$21.5B
$1.11M ﹤0.01%
+18,937
New +$1.08M

Similar funds

Cliff Asness's Q2 2024 Portfolio in Review

As of Q2 2024, Cliff Asness held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Cliff Asness deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Humana, an estimated $237M trimmed.

  • Cliff Asness's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
  • Cliff Asness added most to ExxonMobil in Q2 2024, an estimated $213M increase.
  • Cliff Asness's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
  • Cliff Asness fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
  • Cliff Asness's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
  • Cliff Asness opened 313 new positions and closed 123 in Q2 2024.
  • Cliff Asness's portfolio value rose 11% quarter-over-quarter to $65.2B.

Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.